Health AI Central
Share:
Peer-Reviewed Publication
J Am Geriatr Soc2026;74(6):1788-1791.June 1, 2026Journal Article

The Importance of Age in Selecting a Testing Strategy for Stable Symptomatic Patients With Suspected Coronary Artery Disease.

Evangelia Vemmou1, Michelle D Kelsey2, Sreekanth Vemulapalli2, Daniel B Mark2, Campbell Rogers3, Sarah Mullen3, Whitney Huey3, Aija Caune3, Karen Chiswell4, Robert M Clare4, Eric Yow4, Jonathon A Leipsic5, Robert A Byrne6,7, Nicholas Ng3, Kit Pier8, James E Udelson9, Pamela S Douglas1,4, Michael G Nanna10
1University of California, San Francisco, San Francisco, California, USA.
2Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.
3HeartFlow, Inc., Mountain View, California, USA.
4Duke Clinical Research Institute, Durham, North Carolina, USA.
5Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
6Cardiovascular Research Institute (CVRI) Dublin and Department of Cardiology, Mater Private Network, Dublin, Ireland.
7School of Pharmacy and Biomolecular Sciences, RCSI University, Dublin, Ireland.
8PharPoint Research, Inc, Durham, North Carolina, USA.
9Division of Cardiology, Tufts University, Boston, Massachusetts, USA.
10Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
PubMed PMC DOI PDF

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.